Ms. Sandra Rousselle, SPHR, SHRM-SCP - Vice President in charge of Human Resources Management and External Relations of Mevion, said that the Proton MEVION S250-FIT cancer treatment system is currently developed at a technology level that is almost perfect for the goal of cancer treatment with proton radiation - a superior therapy in cancer treatment in terms of effectiveness and safety at a very high level compared to conventional radiation therapy. This is the latest generation of proton radiation machines, the most advanced, just licensed by the FDA in October 2025 and Stanford Hospital (USA) is the first unit to use it. With the sophistication of the technology, the number of machine systems on the market is very scarce, Vietnam is the 2nd country outside the US to be able to order machine systems, software and technology used in the best version, equivalent to leading hospitals in the world in cancer treatment.
The contract to purchase the latest generation Proton MEVION S250-FIT cancer treatment system has a total value of nearly 20,000 billion VND, officially bringing Vietnam to participate in the world's leading modern cancer treatment network from Mevion, bringing many benefits to patients in Vietnam just like tens of thousands of patients in the US have been treated well by generations of Mevion proton radiation therapy machines in recent years.
Unlike older generation, bulky, and complex proton radiotherapy machines, the latest generation Proton MEVION S250-FIT "super machine" has a compact size, and the transfer, installation, and official operation time is much shorter.
In Asia, Tam Anh General Hospital System is the first unit to successfully sign a contract to purchase the "super machine" Proton MEVION S250-FIT cancer radiotherapy, the latest version integrated with modern AI, opening up opportunities for Vietnamese cancer patients to easily access the world's latest radiation therapy methods right in the country, expected to retain a portion of the billions of US dollars of cancer treatment costs abroad of Vietnamese people each year.
TTND. TS. BS. CKII Pham Xuan Dung, Director of the Oncology Center, Tam Anh General Hospital System, Ho Chi Minh City, said that the Proton MEVION S250-FIT cancer radiation therapy system integrated with the latest generation AI opens up new opportunities for cancer patients with tumors located in deep, complex, sensitive locations (such as cancer of the head, neck, brain, spinal cord, lung, liver...); Maximizing the protection of healthy tissues and important surrounding organs (such as heart, lung, brain...) compared to traditional X-ray radiation therapy, with fewer side effects.
The "Mevinion proton radiation therapy super machine" also especially helps patients experience more positive treatment by minimizing radiation therapy time, patients can sit and lie in the radiation therapy process with a feeling of safety, comfort, and ease.
Mr. Ngo Chi Dung - Chairman of the Board of Directors of Tam Anh General Hospital System, said that Tam Anh for many years has always identified its strategic vision as pioneering the synchronous investment in leading modern technologies and techniques in the world, many first and only equipment in the region and in the country alongside a team of good and experienced doctors and experts.
The event of Tam Anh, Vietnam and Mevion, USA signing a contract to buy - sell the new generation Proton radiation therapy system MEVION S250-FIT is an important milestone not only for the Tam Anh General Hospital System but can also be considered a breakthrough in Vietnam's medical journey to access and master the world's leading modern technology equipment serving medical examination and treatment activities in the field of cancer in Vietnam, continuing to affirm Tam Anh's strategic vision in investing largely and synchronously in medical examination and treatment in general, especially the field of oncology in particular, serving hundreds of millions of Vietnamese people and customers from countries around the world according to international standards on quality, efficiency and high safety," Mr. Ngo Chi Dung emphasized.
